# LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes

> **NCT06527027** · NA · RECRUITING · sponsor: **Copernicus Memorial Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Lymph Node Neoplasm
- Lymph Node Metastasis

## Interventions

- **OTHER:** Lymph node assessment according to RECIST 1.1 in CT
- **OTHER:** Lymph node assessment according to Node-RADS in CT
- **OTHER:** Lymph node assessment according to LN-RADS in CT
- **OTHER:** Lymph node assessment according to RECIST 1.1 in MRI
- **OTHER:** Lymph node assessment according to Node-RADS in MRI
- **OTHER:** Lymph node assessment according to LN-RADS in MRI

## Key facts

- **NCT ID:** NCT06527027
- **Lead sponsor:** Copernicus Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06527027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06527027, "LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06527027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*